February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
Amazon: Slowing Growth Highlights Valuation Risks for Investors
Tesla and Lucid: Strategic Insights for a Long/Short Position
Apple: Resilient Growth and Strategic Innovation Bolster Confidence
Nvidia's Growth Backed by Hyperscaler Spending and AI Industry Momentum
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Anavex Life Sciences (AVXL) stock forecast for 2025
Updated: February 17, 2025 (12:16)
Sector: HealthcareThe share price of Anavex Life Sciences Corp. (AVXL) now
50/200 Day Moving Average: $9.78 / $6.65
This figure corresponds to the Average Price over the previous 50/200 days. For Anavex Life Sciences stocks, the 50-day moving average is the resistance level today.
For Anavex Life Sciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Anavex Life Sciences Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Anavex Life Sciences stock price in 2025. How much will one Anavex Life Sciences share be worth in 2025? Is it worth taking profit / loss on AVXL stock now or waiting? What are analysts' forecasts for Anavex Life Sciences stock?
We forecast Anavex Life Sciences stock performance using neural networks based on historical data on AVXL stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Anavex Life Sciences Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Anavex Life Sciences analysts is $32.63. Today 200 Day Moving Average is the support level (6.65 $). 50 Day Moving Average is the resistance level (9.78 $).
Historical and forecast chart of Anavex Life Sciences Corp. stock
The chart below shows the historical price of Anavex Life Sciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AVXL stock price can be found in the table below.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, is developing drug candidates for the treatment of diseases of the central nervous system (CNS).
Anavex Life Sciences (AVXL) Forecast for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Mar | 9.52 | 7.74 | 10.09 | 23.32 % |
Apr | 8.40 | 6.79 | 8.85 | 23.25 % |
May | 8.00 | 7.12 | 9.11 | 21.91 % |
Jun | 7.54 | 6.72 | 8.19 | 17.89 % |
Jul | 7.00 | 6.32 | 7.43 | 14.91 % |
Aug | 6.44 | 5.68 | 7.32 | 22.38 % |
Sep | 7.28 | 6.11 | 8.57 | 28.74 % |
Oct | 6.72 | 5.77 | 7.44 | 22.53 % |
Nov | 5.98 | 5.52 | 6.65 | 17.04 % |
Dec | 6.84 | 6.05 | 7.39 | 18.20 % |
Anavex Life Sciences information and performance
51 W 52ND STREET,, 7TH FLOOR, NEW YORK, NY, US
Market capitalization of the Anavex Life Sciences Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AVXL shares in the company outstanding by the market price of one share.
EBITDA of Anavex Life Sciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Anavex Life Sciences price target for 2025 by month
Target values for the price of one Anavex Life Sciences share for Mar 2025.
In Mar, the Positive dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 23.321% volatility is expected.
Pessimistic target level: 7.74
Optimistic target level: 10.09
Target values for the price of one Anavex Life Sciences share for Apr 2025.
In Apr, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 23.252% volatility is expected.
Pessimistic target level: 6.79
Optimistic target level: 8.85
Target values for the price of one Anavex Life Sciences share for May 2025.
In May, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 21.910% volatility is expected.
Pessimistic target level: 7.12
Optimistic target level: 9.11
Target values for the price of one Anavex Life Sciences share for Jun 2025.
In Jun, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 17.894% volatility is expected.
Pessimistic target level: 6.72
Optimistic target level: 8.19
Target values for the price of one Anavex Life Sciences share for Jul 2025.
In Jul, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 14.910% volatility is expected.
Pessimistic target level: 6.32
Optimistic target level: 7.43
Target values for the price of one Anavex Life Sciences share for Aug 2025.
In Aug, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 22.379% volatility is expected.
Pessimistic target level: 5.68
Optimistic target level: 7.32
Target values for the price of one Anavex Life Sciences share for Sep 2025.
In Sep, the Positive dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 28.736% volatility is expected.
Pessimistic target level: 6.11
Optimistic target level: 8.57
Target values for the price of one Anavex Life Sciences share for Oct 2025.
In Oct, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 22.527% volatility is expected.
Pessimistic target level: 5.77
Optimistic target level: 7.44
Target values for the price of one Anavex Life Sciences share for Nov 2025.
In Nov, the Negative dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 17.038% volatility is expected.
Pessimistic target level: 5.52
Optimistic target level: 6.65
Target values for the price of one Anavex Life Sciences share for Dec 2025.
In Dec, the Positive dynamics for Anavex Life Sciences Corp. shares will prevail with possible monthly volatility of 18.195% volatility is expected.
Pessimistic target level: 6.05
Optimistic target level: 7.39
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.